Acquired Tear Duct Stenosis (PANDO): A Patient Guide
At a Glance
Acquired tear duct stenosis, also called PANDO, is an adult blockage caused by narrowing and scarring in the tear-drainage system. Persistent watery eyes are common; complete blockages are usually treated with tear-bypass surgery called DCR, while sudden pain and swelling may signal infection.
Acquired tear duct stenosis, often referred to as Primary Acquired Nasolacrimal Duct Obstruction (PANDO), is a condition where the eye’s natural drainage system becomes physically blocked over time. Unlike the blockages some infants are born with, this version develops in adulthood, most frequently affecting women. It is a multifactorial condition that is thought to involve a cycle of chronic, low-grade inflammation in the lining of the tear duct. As this inflammation persists, it is often associated with fibrosis, a process where healthy tissue is replaced by scar tissue that slowly narrows and eventually obstructs the duct [1][2].
The hallmark of this condition is a persistent, overflowing tear, a symptom known as epiphora. Because the tears have no way to drain into the nose, they pool on the surface of the eye and spill over onto the cheek. This is often accompanied by a sticky or mucus-like discharge, as the fluid trapped within the tear sac becomes stagnant. While these symptoms are rarely a threat to your vision, they can be deeply frustrating, causing constant blurred vision, skin irritation, and social embarrassment [3][4]. Because epiphora can also be caused by dry eye, allergies, or eyelid issues, PANDO is a diagnosis made after careful examination.
In most adults with complete blockages, simple procedures like probing or flushing the duct are only temporary solutions, though they may be used for partial stenosis. Instead, the standard of care for complete obstruction is a surgical procedure called Dacryocystorhinostomy (DCR). This surgery creates a brand-new bypass channel that allows tears to drain directly from the eye into the nose, bypassing the blocked segment entirely. Whether performed through a small incision on the skin or internally through the nose, DCR is highly effective, with many patients finding relief from their symptoms, though individual success depends on anatomy and the specific cause [5][6].
While PANDO is generally a chronic and stable condition, it is important to stay vigilant for signs of infection. If the stagnant fluid in the tear sac becomes infected—a condition called acute dacryocystitis—it can cause sudden pain, redness, and a firm, tender swelling in the corner of the eye near the nose. This transition from a watery eye to a painful infection requires prompt medical attention to prevent the inflammation from spreading. For most, however, the path forward involves a clear diagnostic workup and a focus on restoring the natural flow of tears [7][8].
In this guide
5 chapters
Understanding Acquired Tear Duct Blockage (PANDO)
Learn what causes acquired tear duct blockage (PANDO), how it leads to watery eyes and discharge, and how ROPLAS, irrigation, and imaging help find the blockage.
Mapping the Blockage: Biology and Diagnosis
Learn how acquired tear duct stenosis is diagnosed, including PANDO and SANDO, irrigation, Jones dye tests, imaging, and structural versus functional blockage.
Standard Treatments: Rebuilding the Drainage System
Learn how DCR treats acquired tear duct stenosis, including external and endoscopic surgery, silicone stents, recovery, risks, and factors that affect success.
When Tearing Becomes an Emergency: Complications and Red Flags
Learn which complications of acquired tear duct stenosis need urgent care, including dacryocystitis, orbital cellulitis, vision changes, and tumor red flags.
Life After Surgery: Recovery and Long-Term Success
Learn what to expect after DCR for acquired tear duct stenosis, including stent care, warning signs, follow-up tests, persistent tearing, and safe recovery tips.
Common questions in this guide
What is PANDO, and why does it cause constant tearing?
What symptoms are caused by an acquired blocked tear duct?
How can doctors confirm PANDO instead of dry eye or an eyelid problem?
Is surgery always needed for an acquired tear duct blockage?
How does DCR surgery treat a blocked tear duct?
What warning signs suggest that a blocked tear duct is infected?
What is the difference between PANDO and secondary acquired tear duct obstruction?
Get notified when new evidence is published on acquired tear duct stenosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO).
Ali MJ
Progress in retinal and eye research 2023; (96()):101193 doi:10.1016/j.preteyeres.2023.101193.
PMID: 37394093 - 2
The Incidence of Lacrimal Drainage Disorders Across a Tertiary Eye Care Network: Customization of an Indigenously Developed Electronic Medical Record System-eyeSmart.
Das AV, Rath S, Naik MN, Ali MJ
Ophthalmic plastic and reconstructive surgery 2019; (35(4)):354-356 doi:10.1097/IOP.0000000000001257.
PMID: 30407992 - 3
Self-regurgitation on pressure over lacrimal sac in cases of primary-acquired nasolacrimal duct obstruction: Correlation with physician examination and patients' perceptions.
Alam MS, Singh P, Amitava AK, Ali MJ
Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society 2021; (35(3)):217-219 doi:10.4103/SJOPT.SJOPT_87_21.
PMID: 35601852 - 4
Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases.
Makselis A, Petroska D, Kadziauskiene A, et al.
BMC ophthalmology 2022; (22(1)):12 doi:10.1186/s12886-021-02185-x.
PMID: 34986808 - 5
Best treatments available for distal acquired lacrimal obstruction: A systematic review and meta-analysis.
Vinciguerra A, Nonis A, Giordano Resti A, et al.
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 2020; (45(4)):545-557 doi:10.1111/coa.13551.
PMID: 32304619 - 6
Endoscopic dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction: A systematic review and pooled analysis of powered vs. non-powered technique.
Daloiso A, Gaudioso P, Negrisolo M, et al.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2026; (283(5)):2827-2847 doi:10.1007/s00405-025-09961-1.
PMID: 41786947 - 7
Dacryocystitis in a Patent Nasolacrimal Drainage System: A Literature Review.
Fatani D, AlSuhaibani A
Seminars in ophthalmology 2024; (39(8)):595-598 doi:10.1080/08820538.2024.2370829.
PMID: 38915222 - 8
Orbital Cellulitis Secondary to Dacryocystitis: A Case Series and Literature Review.
O'Rourke M, Tang YF, Pick Z, et al.
Ophthalmic plastic and reconstructive surgery 2025; (41(3)):306-314 doi:10.1097/IOP.0000000000002834.
PMID: 39652518
This page explains acquired tear duct stenosis and PANDO for educational purposes and does not replace medical advice. An eye specialist should evaluate persistent tearing, discharge, or painful swelling and recommend appropriate testing or treatment.